Logo
HUMIRA BIOSIMILAR MARKET ANALYSIS
  2. / Market Insights
  3. Humira Biosimilar Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

HUMIRA BIOSIMILAR MARKET ANALYSIS

Humira Biosimilar Market, By Product Type (Biosimilar Humira (Adalimumab), and Interchangeable Biosimilar Humira), By Indication (Rheumatoid Arthritis, Psoriasis, Crohn\\\'s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, and Other Autoimmune Conditions), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Patient Age (Adult Patients, Pediatric Patients, and Geriatric Patients), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Nov 2023
  • Code : CMI5925
  • Pages :155
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Leading Companies

  • Amgen Inc.
  • Samsung Bioepis Co., Ltd.
  • Sandoz International GmbH (Novartis AG)
  • Mylan N.V.
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Coherus BioSciences, Inc.
  • Biogen Inc.
  • AbbVie Inc.
  • Celltrion Inc.
  • Rani Therapeutics Holdings, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co., Inc.
  • Viatris Inc.
  • Alvotech

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.